The Role of Convalescent Plasma and Tocilizumab in the Management of COVID-19 Infection: A Cohort of 110 Patients from a Tertiary Care Hospital in Oman.

Faryal Khamis Ziad A Memish Maher Al Bahrani H Al NummaniD Al RaisiS Al DowaikiS ChhetriF Al FahdiM Al YahyaiNenad PandakZ Al BolushiZ AlarimiS Al HashmiIsa Al Salmi Ibrahim Al-Zakwani

Published in: Journal of epidemiology and global health (2021)

In patients with severe COVID-19 infection, using tocilizumab with convalescent plasma is associated with improvement in inflammatory and ventilatory parameters but no effect on mortality. These findings require validation from randomized clinical trials.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
juvenile idiopathic arthritis
prognostic factors
type diabetes
risk factors
patient reported outcomes
patient reported